News & Updates

Treatment with rituximab (RTX) in patients with moderate-to-severe neuropsychiatric (NP) systemic lupus erythematosus (SLE) appears to result in some improvements and to contribute to the use of a much lower steroid dose at 6 months, suggests a study presented at EULAR 2024.

People with schizophrenia may benefit from cognitive remediation which offers durable improvements in both cognition and psychosocial functioning, as shown in a study.

Depressive symptoms are likely to occur in middle-aged and older men with hypogonadism, but low-grade persistent depressive disorder (LG-PDD) is rare, according to a study.

The presence of coexisting clinical depression and anxiety (DA) is not uncommon in the primary care setting, particularly among younger individuals, patients with diabetes, and women, a Singapore study has shown.